Dr William Weare, MD | |
162 Apman Drive, Inarajan, GU 96915 | |
(671) 828-7501 | |
(671) 828-7504 |
Full Name | Dr William Weare |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 162 Apman Drive, Inarajan, Guam |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801086137 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | M-933 (Guam) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William Weare, MD Po Box 170103, Inarajan, GU 96917-0103 Ph: (671) 828-7501 | Dr William Weare, MD 162 Apman Drive, Inarajan, GU 96915 Ph: (671) 828-7501 |
News Archive
Overweight and obese people looking to drop some pounds and considering one of the popular low-carbohydrate diets, along with moderate exercise, need not worry that the higher proportion of fat in such a program compared to a low-fat, high-carb diet may harm their arteries, suggests a pair of new studies by heart and vascular researchers at Johns Hopkins.
The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.
Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.
TWi Pharmaceuticals, Inc. today announced that it launched its generic version of Par Pharmaceutical's MEGACE ES (megestrol acetate oral suspension) 625mg/5ml after the United States District Court for the District of Maryland reinstated its finding that United States Patent No. 7,101,576 (the '576 Patent) is invalid.
Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.
› Verified 5 days ago